Xinghua Peng

1.0k total citations · 1 hit paper
18 papers, 866 citations indexed

About

Xinghua Peng is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Xinghua Peng has authored 18 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Xinghua Peng's work include Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (3 papers) and Aortic Disease and Treatment Approaches (2 papers). Xinghua Peng is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (3 papers) and Aortic Disease and Treatment Approaches (2 papers). Xinghua Peng collaborates with scholars based in China, Hong Kong and United States. Xinghua Peng's co-authors include Ping Gong, Lintao Cai, Guanjun Deng, Zhihong Sun, Sanpeng Li, Yifan Ma, Lihua Zhou, Wenjun Li, Pengfei Zhang and Zhihong Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

Xinghua Peng

18 papers receiving 858 citations

Hit Papers

Cell-Membrane Immunotherapy Based on Natural Killer Cell ... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinghua Peng China 8 629 311 273 226 158 18 866
Chih‐Sheng Chiang Taiwan 15 609 1.0× 231 0.7× 486 1.8× 139 0.6× 135 0.9× 20 961
Yajing Wen China 8 577 0.9× 347 1.1× 352 1.3× 296 1.3× 67 0.4× 12 1.0k
Si‐Cong Yang China 11 492 0.8× 261 0.8× 312 1.1× 98 0.4× 177 1.1× 18 769
Xiang Xiong China 11 639 1.0× 285 0.9× 398 1.5× 149 0.7× 168 1.1× 14 860
Hai‐Yi Feng China 8 434 0.7× 207 0.7× 264 1.0× 83 0.4× 162 1.0× 11 635
Debra Wu United States 11 381 0.6× 385 1.2× 292 1.1× 251 1.1× 85 0.5× 12 920
Mengbin Ding China 16 524 0.8× 158 0.5× 180 0.7× 126 0.6× 172 1.1× 31 670
Jeremy Rothschild Canada 4 824 1.3× 502 1.6× 694 2.5× 155 0.7× 221 1.4× 7 1.3k
Netra U. Rajesh United States 3 832 1.3× 501 1.6× 696 2.5× 161 0.7× 221 1.4× 5 1.3k
Yong‐Hong Xu China 15 446 0.7× 235 0.8× 245 0.9× 192 0.8× 291 1.8× 23 891

Countries citing papers authored by Xinghua Peng

Since Specialization
Citations

This map shows the geographic impact of Xinghua Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinghua Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinghua Peng more than expected).

Fields of papers citing papers by Xinghua Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinghua Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinghua Peng. The network helps show where Xinghua Peng may publish in the future.

Co-authorship network of co-authors of Xinghua Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Xinghua Peng. A scholar is included among the top collaborators of Xinghua Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinghua Peng. Xinghua Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Deng, Guanjun, Siwei Zhang, Xinghua Peng, et al.. (2024). Methylene Blue: An FDA-Approved NIR-II Fluorogenic Probe with Extremely Low pH Responsibility for Hyperchlorhydria Imaging. SHILAP Revista de lepidopterología. 2(10). 683–688. 13 indexed citations
2.
Jiang, Wenbing, Dongchang Xiao, Cheng Wu, et al.. (2024). Circular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells. Molecular Therapy — Nucleic Acids. 35(3). 102258–102258. 15 indexed citations
3.
Peng, Xinghua, et al.. (2023). A bioinformatics analysis of the susceptibility genes in Stanford type A aortic dissection. Journal of Thoracic Disease. 15(4). 1694–1703. 3 indexed citations
4.
Zhang, Li, et al.. (2022). Research on Fluid Inclusions in Vein Quartz as Higher Purity Quartz Sand. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Sun, Zhihong, Guanjun Deng, Xinghua Peng, et al.. (2021). Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell death. Biomaterials. 279. 121228–121228. 60 indexed citations
6.
Peng, Xinghua, et al.. (2021). Analysis of poor prognostic factors of cerebral nerve after deep hypothermic circulatory arrest in patients with type A aortic dissection.. American Journal of Translational Research. 13(9). 10599–10607. 2 indexed citations
7.
Deng, Guanjun, Xinghua Peng, Zhihong Sun, et al.. (2020). Natural-Killer-Cell-Inspired Nanorobots with Aggregation-Induced Emission Characteristics for Near-Infrared-II Fluorescence-Guided Glioma Theranostics. ACS Nano. 14(9). 11452–11462. 214 indexed citations
8.
Sun, Zhihong, Guanjun Deng, Xinghua Peng, et al.. (2020). Intelligent Photothermal Dendritic Cells Restart the Cancer Immunity Cycle. SSRN Electronic Journal. 1 indexed citations
9.
Ren, Qian, Xin Jiang, Ping Gong, et al.. (2019). Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy. International Journal of Biological Macromolecules. 130. 845–852. 50 indexed citations
10.
Deng, Guanjun, Zhihong Sun, Xinghua Peng, et al.. (2019). Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing Blood-Brain Barrier. Biomaterials. 211. 48–56. 106 indexed citations
11.
Yang, Wenkai, et al.. (2019). PPAR γ/Nnat/NF-κB Axis Involved in Promoting Effects of Adiponectin on Preadipocyte Differentiation. Mediators of Inflammation. 2019. 1–9. 30 indexed citations
12.
Deng, Guanjun, Zhihong Sun, Xinghua Peng, et al.. (2018). Near-infrared fluorescence imaging for vascular visualization and fungal detection in plants. Chemical Communications. 54(94). 13240–13243. 7 indexed citations
13.
Deng, Guanjun, Zhihong Sun, Sanpeng Li, et al.. (2018). Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth. ACS Nano. 12(12). 12096–12108. 353 indexed citations breakdown →
14.
Peng, Xinghua, et al.. (2017). Carbon molecular sieve (cms) design for air separation of buckwheat hulls. SHILAP Revista de lepidopterología. 62. 637–642. 1 indexed citations
15.
Wu, Guojun, et al.. (2005). [In vitro killing activity of the fractional proteins from microtus fortis serum to Schistosoma japonicum juveniles].. PubMed. 23(6). 404–7. 1 indexed citations
16.
Peng, Xinghua. (2002). Observations of the cellular response in the lung and liver of Microtus fortis infected by Schistosoma japonicum and the surface ultrastructure of the worm. Zhongguo renshougonghuanbing zazhi. 3 indexed citations
17.
Peng, Xinghua, et al.. (1983). Hemoglobin Jianghua [beta 120(GH3) LYS leads to ILE]: a new fast-moving variant found in China.. PubMed. 7(4). 321–6. 4 indexed citations
18.
Peng, Xinghua, et al.. (1983). Hemoglobin Jianghua [β120(GH3) LYS→ILE]: A New Fast-Moving Variant Found in China. Hemoglobin. 7(4). 321–326. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026